Molina Healthcare (MOH) EBITDA (2010 - 2026)

Molina Healthcare (MOH) has reported EBITDA for 17 consecutive years, with $145.0 million the latest figure, recorded in Q2 2026.

• Quarterly EBITDA fell 61.13% year-over-year to $145.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $218.0 million (down 86.81% YoY) and the FY2025 annual result came in at $781.0 million, down 54.25% from the prior year.
• EBITDA grew to $145.0 million in Q2 2026 per MOH's latest filing, from $98.0 million in the prior quarter.
• Over the last five years, EBITDA for MOH reached as high as $1.1 billion in Q3 2022 and fell as low as -$162.0 million in Q4 2025.
• A 5-year average of $381.0 million and a median of $380.0 million in 2024 frame the typical range for EBITDA.
• Annual changes were most pronounced in 2022 — EBITDA jumped 383.26% — and 2025, when it plunged 142.63%.
• Year by year, EBITDA stood at $1.1 billion in 2022, then slumped by 70.41% to $316.0 million in 2023, then grew by 20.25% to $380.0 million in 2024, then tumbled by 142.63% to -$162.0 million in 2025, then surged by 189.51% to $145.0 million in 2026.
• According to Business Quant data, EBITDA over the past three periods registered $145.0 million, $98.0 million, and -$162.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.